NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE163078 Query DataSets for GSE163078
Status Public on Feb 23, 2022
Title Dysregulated lipid metabolism blunts the sensitivity of B16F10 melanoma cells to EZH2 inhibitor
Organism Mus musculus
Experiment type Expression profiling by high throughput sequencing
Summary The sensitivity has been the key issue for EZH2 inhibitor in cancer therapy. Although it has been approved by Food and Drug Administration (FDA) in 2020, the relative narrow scope still limits its clinical application. In this study, we utilized B16F10 melanoma cell line which is resistant to EZH2 inhibitor GSK126 to an extent to investigate the underlying mechanism. We found that although the proliferative phenotype didn't show any difference upon treatment with GSK126 at 10 μM, the transcriptome and metabolome changed profoundly. Gene set enrichment analysis and metabolites pathway enrichment analysis revealed that GSK126 induced broad shifts in glucose, amino acids and lipid metabolism. Lipid synthesis were strengthened with elevated abundance of unsaturated fatty acids. We also found attenuated tricarboxylic acid cycle metabolism, and decreased amino acids levels. The liver lipid accumulation and the increased blood triglycerides level after GSK126 treatment were further confirmed in a mouse model. Indeed, the combination of GSK126 and lipolysis agent fenofibrate significantly attenuated the proliferation of B16F10 and increased the sensitivity to GSK126. Therefore, the dysregulated lipid metabolism blunts the sensitivity of B16F10 to GSK126. This study uncovered the iceberg under the sea and identified the Achilles heel of EZH2 inhibitor, so that it provides the novel strategy for further combination therapy.
 
Overall design mRNA profiles of GSK126-treated and DMSO-treated B16F10 melanoma cells
 
Contributor(s) Zhang T, Guo Z, Gong Y, Wang Y, Yin Q, Xue L
Citation(s) 35158113
Submission date Dec 11, 2020
Last update date Feb 24, 2022
Contact name Qianqian Yin
Organization name Peking University Third Hospital
Department Center of Basic Medical Research
Street address 49 North Garden Road, Haidian District
City BEIJING
ZIP/Postal code 100191
Country China
 
Platforms (1)
GPL24247 Illumina NovaSeq 6000 (Mus musculus)
Samples (6)
GSM4971746 DMSO-treated cells rep1
GSM4971747 DMSO-treated cells rep2
GSM4971748 DMSO-treated cells rep3
Relations
BioProject PRJNA684616
SRA SRP297710

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE163078_RAW.tar 11.3 Mb (http)(custom) TAR (of TXT)
GSE163078_gene_expression_FPKM.txt.gz 2.6 Mb (ftp)(http) TXT
SRA Run SelectorHelp
Raw data are available in SRA
Processed data provided as supplementary file
Processed data are available on Series record

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap